Daniela van Eickels M.D.

Daniela van Eickels MD, MPH is an accomplished medical affairs leader with extensive experience in the biopharmaceutical industry. Currently serving as Vice President and Head of Medical Affairs for the Cell Therapy Organization at Bristol Myers Squibb, Daniela has previously held significant roles including Vice President of Global Medical Affairs for Worldwide Hematology and Head of Cell Therapy. Prior to joining Bristol Myers Squibb, Daniela held leadership positions at Kite Pharma, where responsibilities included Executive Director of Global Medical Affairs and Global Program Lead for key therapy programs. Daniela's career also includes impactful roles at Takeda Oncology and Takeda Pharmaceuticals, focusing on hematology and respiratory medical affairs. Daniela holds an MPH in Clinical Epidemiology and Biostatistics from Harvard T.H. Chan School of Public Health and an MD PhD from The University of Bonn.